Dr. Ian Ainsley Seemungal, MD

Dr. Seemungal practices at VHC Health in Arlington, Virginia, part of VHC Health.

Dr. Seemungal's NPI, 1679722433, was assigned on September 16, 2008. Dr. Seemungal holds Virginia license 0101250154.

Dr. Seemungal's primary practice is VHC Health, at 1701 North George Mason Drive, Arlington, VA 22205 in Arlington County. The practice phone is (703) 558-5000.

Dr. Seemungal's primary practice is VHC Health in Arlington, Virginia, part of VHC Health. The medical group on file is VHC Health Maternal Fetal Medicine - Arlington. Dmand AI also links Dr. Seemungal to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seemungal practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Seemungal's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Seemungal is licensed in Virginia.

CMS data shows 1,220 Medicare services from Dr. Seemungal across 6 procedure codes in 2024, for 308 Medicare patients. Medicare paid $144,156 for them.

CMS counts 308 Medicare patients who saw Dr. Seemungal in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seemungal's median patient age at 69, with 41% women.

In 2024, Dr. Seemungal wrote 395 Medicare Part D claims for 100 patients. 67% of them were for generic drugs. CMS names the drug for 251 of them, across 11 drugs with 11 or more claims each, at $340,686 in total drug cost. In 2023, CMS named 228 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Seemungal for performance year 2024, reported as part of a group. Dr. Seemungal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seemungal as offering telehealth.

Dmand AI links 3 papers to Dr. Seemungal, published from 2016 to 2017. Dr. Seemungal has published most often in Infect Control Hosp Epidemiol. Dr. Seemungal's most frequent co-authors are Laurel A. Cushing, MD, Rohit M. Modak, MD and Hana Akselrod, MD, MPH.

CMS Open Payments shows 51 general payments to Dr. Seemungal from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Gilead Sciences, Inc. paid the most, $368.